Smiths Medical 21-8011-24 - PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 10.2FR SILICONE CATHETER 11FR INTRODUCER

The Smiths Medical 21-8011-24 Port Infusion Dual Lumen Titanium Port is designed for reliable long-term vascular access in clinical environments where dependable infusion performance, patient comfort, and procedural efficiency are essential. This configuration includes a dual lumen titanium port, a detached 10.2 Fr silicone catheter, and an 11 Fr introducer, supporting controlled access for infusion therapy, medication administration, blood sampling, and other approved vascular access applications.

Built with a durable titanium port body and a flexible silicone catheter, this infusion port system is intended to help healthcare professionals manage patients who require repeated venous access while reducing the need for frequent peripheral needle placement. Its dual lumen design allows clinicians to manage compatible therapies through separate access pathways when clinically appropriate.

Key Benefits

The Smiths Medical 21-8011-24 infusion port offers a strong combination of durability, access flexibility, and clinical usability. The titanium port construction supports long-term performance, while the silicone catheter is designed to provide flexibility within vascular access procedures. The detached catheter format gives clinicians additional control during placement and positioning according to institutional protocol.

The dual lumen configuration is beneficial in care settings where separate infusion channels may be required. This can help streamline therapy delivery, support efficient patient management, and reduce the clinical burden associated with repeated vascular access. The included 11 Fr introducer supports procedural placement and helps standardize the access process for trained clinicians.

Compatibility and Applications

The Smiths Medical 21-8011-24 Port Infusion Dual Lumen Titanium Port is intended for use by qualified healthcare professionals in appropriate vascular access procedures. It may be used in hospitals, oncology departments, infusion centers, interventional radiology suites, surgical settings, and other clinical environments where long-term implanted venous access is required.

Common applications may include infusion therapy, chemotherapy administration, parenteral nutrition, antibiotic therapy, blood draws, and other medically indicated treatments that require repeated vascular access. Compatibility should always be confirmed with the facilitys clinical protocols, approved infusion systems, non-coring access needles, medication requirements, and the products official instructions for use.

Usage Guidelines

This device should be used only by trained and authorized healthcare professionals familiar with implanted port placement, vascular access management, sterile technique, and institutional safety protocols. Prior to use, inspect the packaging and product components to confirm that the device is intact, sterile, and within the applicable expiration date.

Placement, access, flushing, maintenance, and removal should be performed in accordance with the product instructions for use, facility policy, and applicable clinical standards. Only appropriate non-coring needles should be used to access the port. Clinicians should verify patency, confirm proper placement when required, and monitor the patient for signs of complications such as infection, occlusion, infiltration, thrombosis, catheter damage, or access site irritation.

Certifications and Safety Standards

Smiths Medical vascular access products are manufactured for clinical use and are expected to meet applicable medical device quality, safety, and performance requirements. Healthcare facilities should review the product labeling, packaging, and official documentation for specific regulatory status, sterility information, material details, and compliance references.

For safe use, clinicians should follow aseptic technique, approved access procedures, sharps safety practices, and all relevant institutional policies. The product should not be used if packaging is damaged, sterility is compromised, or the device appears defective.

Comparison with Competitors

Compared with standard single lumen implanted ports, the Smiths Medical 21-8011-24 dual lumen titanium port provides added access flexibility for patients who may require separate infusion pathways. The titanium port body offers durability for long-term implanted access, while the silicone catheter supports flexibility during placement and ongoing vascular access management.

When compared with general-purpose infusion access devices, this port system is better suited for patients requiring repeated or long-term therapy rather than short-term peripheral access. The inclusion of a detached 10.2 Fr silicone catheter and 11 Fr introducer also supports procedural customization and efficient placement by trained clinicians.

Typical User Profile and Application Scenarios

This product is typically used by surgeons, interventional radiologists, oncology clinicians, infusion therapy teams, vascular access specialists, and hospital-based healthcare professionals. It is appropriate for patients who require reliable implanted venous access for ongoing treatment plans and frequent clinical access.

Typical scenarios include oncology treatment programs, long-term intravenous therapy, medication regimens requiring dependable vascular access, patients with difficult peripheral access, and clinical care plans that benefit from an implanted dual lumen port system. Patient selection should always be based on clinical judgment, diagnosis, therapy requirements, and institutional guidelines.

Best Practices for Use and Maintenance

To support optimal performance, the Smiths Medical 21-8011-24 port should be handled using strict sterile technique throughout placement and access. Clinicians should follow the recommended flushing and locking protocols, use compatible solutions, and document access, maintenance, and patient response according to facility policy.

Routine assessment of the port site is important to identify redness, swelling, pain, leakage, fever, or other signs that may indicate complications. Staff should use only approved access devices and avoid excessive force during flushing or infusion. Proper patient education may also help improve care continuity by encouraging patients to report discomfort, changes at the site, or difficulty during infusion appointments.

Regulatory and Safety Information

The Smiths Medical 21-8011-24 Port Infusion Dual Lumen Titanium Port should be used only for its intended clinical purpose and according to the manufacturers instructions for use. It is a medical device intended for professional healthcare environments and should not be used by untrained individuals.

Healthcare providers are responsible for confirming product suitability before use, following all applicable regulatory requirements, and complying with facility protocols for implanted vascular access devices. Any adverse events, device concerns, or performance issues should be managed according to institutional reporting procedures and applicable regulatory guidance.

How to Order

Select the Smiths Medical 21-8011-24 PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 10.2FR SILICONE CATHETER 11FR INTRODUCER and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.